6 Matching Annotations
  1. May 2026
  2. aacrjournals.org aacrjournals.org
    Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results From the Phase 2 LEAP-005 Study
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerrescommun/article/6/3/673/776487/Lenvatinib-plus-Pembrolizumab-for-Patients-with
  3. Jun 2025
  4. 52.53.155.43 52.53.155.43
    PDF-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/22f68322b948f74711c059b254f94e963af26ed4/PDF-html.html
  5. Apr 2025
  6. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11964177/
  7. Nov 2024
  8. www.sciencedirect.com www.sciencedirect.com
    Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S009286742401198X
  9. Apr 2024
  10. www.sciencedirect.com www.sciencedirect.com
    Multi-omic profiling reveals the endogenous and neoplastic responses to immunotherapies in cutaneous T cell lymphoma
    2
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379124001964